India, the world’s capital of diabetes, has an escalating diabetes epidemic. Diabetes, a non-communicable disease, affects about 8.7% Indians today, and this number is predicted to hit 70 million by 2025 and 80 million by 2030. Although the exact reasons for this rapid rise in diabetes in the country are not yet clear, experts blame it on multiple factors. In a recent study, researchers from the USA, Germany and India have investigated the status of diabetic care among Indian adults. The findings, published in the journal BMC Medicine, present a grim picture of diabetes management in different states and socio-demographic groups in India.
You are here
Antibiotics, drugs used to treat bacterial infections, have been pivotal in curing many bacterial diseases since its discovery in 1928. However, an emerging threat to using them is the rise of bacterial strains that are resistant to antibiotics. In a recent study, a team of researchers have used Drug Resistance Index (DRI) to measure the effectiveness of antibiotics against specific bacteria.
Visceral leishmaniasis, or kala-azar, is an insidious disease that affects thousands of people every year. This illness can be fatal, if not diagnosed and treated on time. However, despite best efforts, India still lags behind in eliminating this disease completely. A recent study published in the journal PLOS Neglected Tropical Diseases has investigated the factors that lead to the delayed diagnosis and treatment of kala-azar.